NovaScan
Milwaukee, United States· Est.
NovaScan develops AI-enhanced cancer detection technology including MarginScan™ for real-time surgical margin assessment.
Private Company
Total funding raised: $2.4M
About
NovaScan develops AI-enhanced cancer detection technology including MarginScan™ for real-time surgical margin assessment.
Diagnostics
Funding History
2Total raised:$2.4M
Seed$2.1M
Grant$250K